Search research articles
Contact Us
Filters
Showing results (341-350 of 367) with videos related to
Page
of 37
Sort By:
The New England Journal of Medicine
|
March 2, 2022
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Laura L Hammitt, Ron Dagan, Yuan Yuan, et al.
Human Vaccines & Immunotherapeutics
|
August 7, 2020
TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines
Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)
Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.
The New England Journal of Medicine
|
April 5, 2023
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants
William J Muller, Shabir A Madhi, Beatriz Seoane Nuñez, et al.
Microbial Genomics
|
June 12, 2019
Putative novel cps loci in a large global collection of pneumococci
Andries J van Tonder, Rebecca A Gladstone, Stephanie W Lo, et al.
Plos One
|
March 19, 2015
A novel host-proteome signature for distinguishing between acute bacterial and viral infections
Kfir Oved, Asi Cohen, Olga Boico, et al.
Lancet (London, England)
|
June 13, 2006
Pneumococcal vaccination in developing countries
Orin S Levine, Katherine L O'Brien, Maria Knoll, et al.
Scientific Reports
|
January 12, 2018
Flavin Reductase Contributes to Pneumococcal Virulence by Protecting from Oxidative Stress and Mediating Adhesion and Elicits Protection Against Pneumococcal Challenge
Giora I Morozov, Nurith Porat, Tatyana Kushnir, et al.
Nature Communications
|
April 8, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials
Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Nature Communications
|
July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials
Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 367) with videos related to
Sort By:
Page
of 37
The New England Journal of Medicine
|
March 2, 2022
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Laura L Hammitt, Ron Dagan, Yuan Yuan, et al.
Human Vaccines & Immunotherapeutics
|
August 7, 2020
TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines
Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)
Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.
The New England Journal of Medicine
|
April 5, 2023
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants
William J Muller, Shabir A Madhi, Beatriz Seoane Nuñez, et al.
Microbial Genomics
|
June 12, 2019
Putative novel cps loci in a large global collection of pneumococci
Andries J van Tonder, Rebecca A Gladstone, Stephanie W Lo, et al.
Plos One
|
March 19, 2015
A novel host-proteome signature for distinguishing between acute bacterial and viral infections
Kfir Oved, Asi Cohen, Olga Boico, et al.
Lancet (London, England)
|
June 13, 2006
Pneumococcal vaccination in developing countries
Orin S Levine, Katherine L O'Brien, Maria Knoll, et al.
Scientific Reports
|
January 12, 2018
Flavin Reductase Contributes to Pneumococcal Virulence by Protecting from Oxidative Stress and Mediating Adhesion and Elicits Protection Against Pneumococcal Challenge
Giora I Morozov, Nurith Porat, Tatyana Kushnir, et al.
Nature Communications
|
April 8, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials
Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Nature Communications
|
July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials
Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Page
of 37